Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Therapeutics - Page 34

Therapeutics

Oragenics SARS-CoV-2 spike protein produced neutralizing antibodies with Intramuscular and intranasal adjuvants
Biotechnology | COVID-19 | NIH | Therapeutics | Vaccine

Oragenics SARS-CoV-2 spike protein produced neutralizing antibodies with Intramuscular and intranasal adjuvants

On Aug. 30, 2021, Oragenics announced that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator…

Read More Oragenics SARS-CoV-2 spike protein produced neutralizing antibodies with Intramuscular and intranasal adjuvantsContinue

Monoclonal antibody treatment combo reduced hospitalization among high-risk patients with COVID-19
Biotechnology | COVID-19 | Infectious Disease | Non-Profit Research | Therapeutics

Monoclonal antibody treatment combo reduced hospitalization among high-risk patients with COVID-19

On Aug. 30, 2021, the Mayo Clinic reported that in an observational study the combination of casirivimab and…

Read More Monoclonal antibody treatment combo reduced hospitalization among high-risk patients with COVID-19Continue

UBC study examines ‘Achilles’ heel’ of cancer tumours, paving the way for new treatment strategies
Biotechnology | Diagnostics | Disease | Medicine | Non-Profit Research | Oncology | Therapeutics

UBC study examines ‘Achilles’ heel’ of cancer tumours, paving the way for new treatment strategies

On Aug. 27, 2021, researchers at University of British Columbia’s (UBC) faculty of medicine and BC Cancer Research…

Read More UBC study examines ‘Achilles’ heel’ of cancer tumours, paving the way for new treatment strategiesContinue

Spacestation astronauts successfully demonstrated DNA repair in space using CRISPR technology
Biotechnology | CRISPR | Diagnostics | Disease | Therapeutics

Spacestation astronauts successfully demonstrated DNA repair in space using CRISPR technology

On Aug. 27, 2021, National Aeronautics and Space Administration (NASA) Space station astronauts successfully demonstrated DNA repair in…

Read More Spacestation astronauts successfully demonstrated DNA repair in space using CRISPR technologyContinue

Study confirmed virus variants reduce protection against COVID-19
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

Study confirmed virus variants reduce protection against COVID-19

On Aug. 26, 2021, Oregon Health & Science University (OHSU) announced a laboratory study found that blood serum…

Read More Study confirmed virus variants reduce protection against COVID-19Continue

Pfizer and BioNTech announced collaboration with Brazil’s Eurofarma to manufacture COVID-19 vaccine doses
Biotechnology | COVID-19 | Life Science History | Therapeutics | Vaccine

Pfizer and BioNTech announced collaboration with Brazil’s Eurofarma to manufacture COVID-19 vaccine doses

On Aug. 26, 2021, Pfizer and BioNTech announced the signing of a letter of intent with Eurofarma Laboratorios,…

Read More Pfizer and BioNTech announced collaboration with Brazil’s Eurofarma to manufacture COVID-19 vaccine dosesContinue

Anixa Biosciences’ Covid-19 compounds expected to be effective against the Delta variant
Biotechnology | Infectious Disease | Therapeutics

Anixa Biosciences’ Covid-19 compounds expected to be effective against the Delta variant

On Aug. 25, 2021, Anixa Biosciences announced that a genomic variant analysis indicateed that its potential compounds may…

Read More Anixa Biosciences’ Covid-19 compounds expected to be effective against the Delta variantContinue

Pfizer and BioNTech initiated rolling submission of SBLA to U.S. FDA for booster dose of COMIRNATY in individuals 16 and Older
Biotechnology | COVID-19 | FDA | Pharmaceutical | Therapeutics

Pfizer and BioNTech initiated rolling submission of SBLA to U.S. FDA for booster dose of COMIRNATY in individuals 16 and Older

On Aug. 25, 2021, Pfizer and BioNTech announced the initiation of a supplemental Biologics License Application (sBLA) to…

Read More Pfizer and BioNTech initiated rolling submission of SBLA to U.S. FDA for booster dose of COMIRNATY in individuals 16 and OlderContinue

Pfizer-BioNTech COVID-19 vaccine COMIRNATY received full U.S. FDA approval for individuals 16 years and older
Biotechnology | COVID-19 | FDA | Pharmaceutical | Therapeutics

Pfizer-BioNTech COVID-19 vaccine COMIRNATY received full U.S. FDA approval for individuals 16 years and older

On Aug. 23, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…

Read More Pfizer-BioNTech COVID-19 vaccine COMIRNATY received full U.S. FDA approval for individuals 16 years and olderContinue

Vaccines still effective against Delta variant of concern, says Oxford-led study of the COVID-19 Infections Survey
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

Vaccines still effective against Delta variant of concern, says Oxford-led study of the COVID-19 Infections Survey

On Aug. 19, 2021, the University of Oxford reported that obtaining two vaccine doses remained the most effective…

Read More Vaccines still effective against Delta variant of concern, says Oxford-led study of the COVID-19 Infections SurveyContinue

clinical trial tested donated antibodies for effectiveness in fighting infection caused by Coronavirus
COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics

clinical trial tested donated antibodies for effectiveness in fighting infection caused by Coronavirus

On Aug. 19, 2021, Oregon Health & Science University (OHSU) announced that it was part of a randomized,…

Read More clinical trial tested donated antibodies for effectiveness in fighting infection caused by CoronavirusContinue

Antibodies elicited by COVID-19 vaccination effective against delta variant
COVID-19 | Therapeutics | Vaccine

Antibodies elicited by COVID-19 vaccination effective against delta variant

On Aug. 17, 2021, researchers reported the delta variant of the virus that causes COVID-19 was not particularly…

Read More Antibodies elicited by COVID-19 vaccination effective against delta variantContinue

FDA approved Merck’s hypoxia-inducible factor-2 alpha inhibitor WELIREG (belzutifan)
Biotechnology | FDA | Neurology | Oncology | Therapeutics

FDA approved Merck’s hypoxia-inducible factor-2 alpha inhibitor WELIREG (belzutifan)

On Aug. 13, 2021, Merck announced that the U.S. Food and Drug Administration (FDA) had approved WELIREG, an…

Read More FDA approved Merck’s hypoxia-inducible factor-2 alpha inhibitor WELIREG (belzutifan)Continue

Innovation Pharmaceuticals’ phase 2 clinical trial of Brilacidin for COVID-19 trial database under review in preparation for lock
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics

Innovation Pharmaceuticals’ phase 2 clinical trial of Brilacidin for COVID-19 trial database under review in preparation for lock

On Aug. 12, 2021, Innovation Pharma released information regarding the status of its randomized, double-blind, placebo-controlled Phase 2…

Read More Innovation Pharmaceuticals’ phase 2 clinical trial of Brilacidin for COVID-19 trial database under review in preparation for lockContinue

WHO’s Solidarity clinical trial entered a new phase with three new candidate drugs
COVID-19 | Therapeutics | WHO

WHO’s Solidarity clinical trial entered a new phase with three new candidate drugs

On Aug. 11, 2021, the World Health Organization (WHO) announced the next phase in its Solidarity trial that…

Read More WHO’s Solidarity clinical trial entered a new phase with three new candidate drugsContinue

CytoDyn received clearance from Brazil’s FDA (ANVISA) to commence pivotal phase 3 trial in critically ill COVID-19 patients
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

CytoDyn received clearance from Brazil’s FDA (ANVISA) to commence pivotal phase 3 trial in critically ill COVID-19 patients

On Aug. 3, 2021, CytoDyn announced that Brazil’s regulatory authority ANVISA (Agência Nacional de Vigilância Sanitária) has approved…

Read More CytoDyn received clearance from Brazil’s FDA (ANVISA) to commence pivotal phase 3 trial in critically ill COVID-19 patientsContinue

FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19
COVID-19 | FDA | Therapeutics

FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19

On Jul. 29, 2021, Incyte announced the U.S. Food and Drug Administration (FDA) had broadened the Emergency Use…

Read More FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19Continue

FDA Approved Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
Biotechnology | FDA | Therapeutics

FDA Approved Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

On Jul. 29, 2021, BOTOX(R) Allergan, an AbbVie company, announced that the U.S. Food and Drug Administration (FDA)…

Read More FDA Approved Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb SpasticityContinue

NIH unveiled new online tool to improve Alzheimer’s clinical trials recruitment
Disease | Therapeutics

NIH unveiled new online tool to improve Alzheimer’s clinical trials recruitment

On Jul. 29, 2021, the National Institutes of Health announced it had launched a new online research tool…

Read More NIH unveiled new online tool to improve Alzheimer’s clinical trials recruitmentContinue

SIGA announced collaboration with Oxford University to expanded Access Protocol for Use of TPOXX in Central African Republic
Biotechnology | Therapeutics

SIGA announced collaboration with Oxford University to expanded Access Protocol for Use of TPOXX in Central African Republic

On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…

Read More SIGA announced collaboration with Oxford University to expanded Access Protocol for Use of TPOXX in Central African RepublicContinue

Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variants
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variants

On Jul. 29, 2021, Cocrystal Pharma announced that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed…

Read More Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variantsContinue

The COVID-19 Vaccine
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | FDA | Life Science History | Therapeutics | Vaccine

The COVID-19 Vaccine

Cast of Characters: Donald Trump, President | Mike Pence, Vice President | Anthony S. Fauci, MD, Director, National…

Read More The COVID-19 VaccineContinue

COVID-19 vacation Destinations
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine

COVID-19 vacation Destinations

Planning a Summer vacation? Where to go? How about going to one of those large events with tens…

Read More COVID-19 vacation DestinationsContinue

Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant booster
Biotechnology | COVID-19 | Infectious Disease | Life Science History | Therapeutics | Vaccine

Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant booster

On Jul. 22, 2021, Moderna announced a new supply agreement with Taiwan for 20 million doses of Moderna’s…

Read More Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant boosterContinue

Merck Announces FDA approval of VAXNEUVANCE  for prevention of invasive pneumococcal disease
Biotechnology | FDA | Medicine | Pharmaceutical | Therapeutics

Merck Announces FDA approval of VAXNEUVANCE for prevention of invasive pneumococcal disease

On Jul. 16, 2021, Merck announced the U.S. Food and Drug Administration (FDA) had approved VAXNEUVANCE (Pneumococcal 15-valent…

Read More Merck Announces FDA approval of VAXNEUVANCE for prevention of invasive pneumococcal diseaseContinue

CDC and Texas confirmed Monkeypox In U.S. traveler
Biotechnology | CDC | Diagnostics | Infectious Disease | Therapeutics

CDC and Texas confirmed Monkeypox In U.S. traveler

On Jul. 16, 2021, the U.S. Centers for Disease Control and Prevention (CDC) announced and the Texas Department…

Read More CDC and Texas confirmed Monkeypox In U.S. travelerContinue

Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics

Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate

On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…

Read More Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rateContinue

Collaboration created world’s largest browsable resource linking rare protein-coding genetic variants to human disease
Biotechnology | Diagnostics | Disease | Therapeutics

Collaboration created world’s largest browsable resource linking rare protein-coding genetic variants to human disease

On Jul. 8, 2021, access to the world’s largest browsable resource linking rare protein-coding genetic variants to human…

Read More Collaboration created world’s largest browsable resource linking rare protein-coding genetic variants to human diseaseContinue

SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Monkeypox case in the UK
Biotechnology | Therapeutics

SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Monkeypox case in the UK

On Jun. 30, 2021, SIGA Technologies announced that it had provided TPOXX (tecovirimat) to Liverpool University Hospitals NHS…

Read More SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Monkeypox case in the UKContinue

COVID-19 PPE distribution
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Genomics | Life Science History | Medicine | Therapeutics | U.S. Congress | Vaccine

COVID-19 PPE distribution

Cast of Characters: Jay Inslee, Governor, Washington | Gavin Newsom, Governor, California | Doug Ducey, Governor, Arizona |…

Read More COVID-19 PPE distributionContinue

Page navigation

Previous PagePrevious 1 … 32 33 34 35 36 … 117 Next PageNext
  • Categories
  • Timeline
  • Aesthetics
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Olfactory
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Quantum
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1710
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2026 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search